正文：
近期，中国医药卫生系统反腐力度持续加大，多名官员因违纪违法行为被处理。据中国新闻网报道，广东省卫生健康委员会原党组书记、主任段宇飞被开除党籍和公职，其涉嫌犯罪问题被移送检察机关依法审查起诉，所涉财物一并移送。
段宇飞被查是医药卫生系统反腐行动的又一例证。今年以来，医药领域反腐频现新动态，截至8月2日，已有超过220名医药卫生系统“关键少数”被查，涵盖地方卫健、医保、药监领域“一把手”以及医院、药企管理层等。
广东省纪委监委近期通报了多起医药卫生系统官员违纪违法案例。原党组书记、主任朱宏被开除党籍和公职，涉嫌犯罪问题移送检察机关审查起诉。朱宏被指利用职务便利，在医疗设备采购、工程款拨付等方面为他人谋利，构成严重职务违法并涉嫌受贿犯罪。
陈元胜，原广东省卫计委党组副书记、主任，去年10月被查，今年1月被开除党籍，通报显示其利用职务上的便利，非法收受巨额财物。
此外，广东省药品监督管理局原党组书记、局长江效东，广东省药品监督管理局原一级巡视员苏盛锋也于同日被通报受处分。
基层卫生院的贪腐问题同样受到关注。四川泸定县泸桥镇中心卫生院原院长王莲庆因将卫生院变成“腐败圈”，秘密进行“分赃大会”，被立案审查调查。王莲庆安排卫生院相关人员套取基本公共卫生服务资金139万余元，并组织全体职工开会串供统一口径，伪造账本和资料，试图掩盖事实。
医药反腐长效机制正在加速建立。除了加强监管、整治，今年医药反腐工作还着眼于长效机制的建立，旨在从源头上遏制医药卫生系统的腐败行为，确保医疗资源的合理使用和患者权益的保障。
此次医药反腐行动表明了中国政府打击医药卫生系统腐败的决心，旨在构建一个更加透明、高效的医疗体系，提升公众对医疗服务的信任和满意度。
英语如下：
News Title: “Pharmaceutical Anti-Corruption Crackdown: Health Director Involved in Bribe-Taking Scandal Investigated”
Keywords: Anti-Corruption, Pharmaceuticals, Investigation
News Content:
Title: Pharmaceutical Anti-Corruption Efforts Deepen, with Multiple Individuals Sanctioned
Article:
In recent times, the anti-corruption efforts within China’s pharmaceutical and health sector have been intensifying, with multiple officials being disciplined for violations of discipline and law. According to China News Service, the original party secretary and director of the Guangdong Provincial Health Commission, Duan Yuxi, was expelled from the party and dismissed from his position, and his suspected criminal issues were transferred to the procuratorial organs for legal review and prosecution, along with the related assets.
Duan Yuxi’s investigation is another example of the anti-corruption action within the pharmaceutical and health sector. This year, there have been frequent new developments in pharmaceutical sector anti-corruption, with over 220 key individuals within the pharmaceutical and health sector being investigated as of August 2, covering top leaders in local health commissions, medical insurance, drug regulatory bodies, as well as management teams in hospitals and pharmaceutical companies.
The Guangdong Provincial Commission for Discipline Inspection recently reported several cases of officials in the pharmaceutical and health sector who had violated discipline and law. The original party secretary and director, Zhu Hong, was expelled from the party and dismissed from his position, and his suspected criminal issues were transferred to the procuratorial organs for review and prosecution. Zhu Hong was accused of using his position to benefit others in medical equipment procurement, bill payments, and other areas, constituting serious violations of duty and suspected bribery crime.
Chen Yongsheng, the original party secretary and director of the Guangdong Provincial Health Commission, was investigated in October last year and expelled from the party in January this year. The report showed that he illegally accepted large amounts of property using his position.
In addition, the original party secretary and director of the Guangdong Provincial Food and Drug Administration, Jiang Xiaodong, and the original first-level inspector of the Guangdong Provincial Food and Drug Administration, Su Shengfeng, were also reported to have been disciplined on the same day.
The corruption issues in grassroots health institutions are also under scrutiny. Wang Lianqing, the original director of the Zhaiqiao Central Hospital of Longding County, Sichuan Province, was investigated for turning the hospital into a “corruption circle” and holding secret “bribe-taking meetings”. Wang Lianqing arranged for staff at the hospital to embezzle basic public health service funds of over 1.39 million yuan and organized all employees to meet and provide consistent statements, falsify account books and documents, attempting to cover up the facts.
The establishment of a long-term mechanism for pharmaceutical anti-corruption is accelerating. In addition to strengthening regulation and rectification, this year’s pharmaceutical anti-corruption work has also focused on the establishment of a long-term mechanism aimed at preventing corruption in the pharmaceutical and health sector from the source, ensuring the rational use of medical resources and the protection of patients’ rights.
This pharmaceutical anti-corruption action demonstrates the Chinese government’s determination to combat corruption within the pharmaceutical and health sector, aiming to build a more transparent and efficient medical system to enhance public trust and satisfaction with medical services.
【来源】http://www.chinanews.com/sh/2024/08-02/10262498.shtml
Views: 1